Core Insights - MedWell Ai, Inc. has filed its Quarterly Report for the financial period ending December 31, 2025, indicating a focus on AI-driven solutions in the healthcare and wellness sectors [1] Financial Performance - The company reported total revenues of $548,315 for the fiscal second quarter of 2025, marking a significant strategic shift towards AI-driven healthcare and wellness products [2] - For the three months ending December 31, 2025, total revenues increased by over 280% compared to $142,861 for the same period in 2024 [6] - For the six months ending December 31, 2025, total revenues reached $1,075,806, a 700% increase from $144,009 in the same period of 2024 [6] Operational Efficiency - The company reduced its net loss to $266,221 for the three months ending December 31, 2025, down from $315,096 in the same period of 2024 [6] - For the six months ending December 31, 2025, the net loss was reduced to $592,255 from $904,080 in the same period of 2024 [6] - General and administrative expenses were reduced to $388,509 for the three months ending December 31, 2025, compared to $625,199 for the same period in 2024 [6] Strategic Focus - The CEO highlighted the company's growth in the B2B pharmaceutical procurement sector, particularly in high-demand wellness products like compounded GLP-1 agonists for weight management [4] - The revenue growth aligns with trends in longevity, personalized medicine, and corporate wellness markets, indicating a successful scaling process in a competitive environment [5]